Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guohao Xia

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cell Death & Disease|July 14, 2020
LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1Jiayuan Huang, Banzhou Pan, Guohao Xia, et al.
Journal of Thoracic Disease|January 10, 2018
Role of the stromal cell derived factor-1/CXC chemokine receptor 4 axis in the invasion and metastasis of lung cancer and mechanismYun Zeng, Xinwei Wang, Bijian Yin, et al.
Journal of Thoracic Disease|June 24, 2021
Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation: a retrospective analysisRan Hu, Zhiting Zhao, Yue Shi, et al.
Experimental Lung Research|July 19, 2017
Effects of the Notch1 signaling pathway on human lung cancer A549 cellsYun Zeng, Bijian Yin, Xinwei Wang, et al.
Chemical Communications (Cambridge, England)|March 2, 2026
Degradation and interfacial chemistry of inorganic cathodes for potassium-ion batteriesWeiwei Sun, Shiyan Zhu, Mingxuan Gu, et al.
Translational Lung Cancer Research|April 14, 2023
Transformation of <i>ALK</i>-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case reportGuohao Xia, Jiayuan Huang, Jie Ni, et al.
ACS Applied Materials & Interfaces|January 27, 2025
Adaptive Phase Change Microcapsules for Efficient Sustainable CoolingShuqi Zhang, Guohao Xia, Qian Zhu, et al.
Frontiers in Oncology|January 26, 2023
Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective studyZhiting Zhao, Luqing Zhao, Guohao Xia, et al.
Investigational New Drugs|September 5, 2017
Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignanciesMeiqi Shi, Jing Sun, Jinsong Zhou, et al.
The Lancet. Oncology|February 28, 2025
Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm studyZiming Li, Yan Wang, Yuping Sun, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cell Death & Disease|July 14, 2020
LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1Jiayuan Huang, Banzhou Pan, Guohao Xia, et al.
Journal of Thoracic Disease|January 10, 2018
Role of the stromal cell derived factor-1/CXC chemokine receptor 4 axis in the invasion and metastasis of lung cancer and mechanismYun Zeng, Xinwei Wang, Bijian Yin, et al.
Journal of Thoracic Disease|June 24, 2021
Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation: a retrospective analysisRan Hu, Zhiting Zhao, Yue Shi, et al.
Experimental Lung Research|July 19, 2017
Effects of the Notch1 signaling pathway on human lung cancer A549 cellsYun Zeng, Bijian Yin, Xinwei Wang, et al.
Chemical Communications (Cambridge, England)|March 2, 2026
Degradation and interfacial chemistry of inorganic cathodes for potassium-ion batteriesWeiwei Sun, Shiyan Zhu, Mingxuan Gu, et al.
Translational Lung Cancer Research|April 14, 2023
Transformation of <i>ALK</i>-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case reportGuohao Xia, Jiayuan Huang, Jie Ni, et al.
ACS Applied Materials & Interfaces|January 27, 2025
Adaptive Phase Change Microcapsules for Efficient Sustainable CoolingShuqi Zhang, Guohao Xia, Qian Zhu, et al.
Frontiers in Oncology|January 26, 2023
Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective studyZhiting Zhao, Luqing Zhao, Guohao Xia, et al.
Investigational New Drugs|September 5, 2017
Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignanciesMeiqi Shi, Jing Sun, Jinsong Zhou, et al.
The Lancet. Oncology|February 28, 2025
Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm studyZiming Li, Yan Wang, Yuping Sun, et al.
Pageof 2